{"symbol":"JNJ","fiscalQuarter":"Q4-2016","reportDate":"2017-01-24","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2016","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Down N/A","keyNumbers":[{"metric":"EPS","actual":"$1.58","expected":"N/A","surprise":"+1.54%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our performance this quarter.","Our focus remains on innovation and meeting consumer needs."],"summary":"Management expressed satisfaction with the earnings performance, highlighting their commitment to innovation. They emphasized the importance of adapting to market demands."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"This earnings report shows that Johnson & Johnson exceeded expectations on EPS, which is a positive sign for the company. However, the lack of revenue data and guidance may leave investors cautious. The stock reaction is not available, indicating uncertainty in market response.","metaDescription":"Johnson & Johnson (JNJ) Q4 2016 earnings: EPS beat by 1.54%. Stock reaction not available. Full breakdown."}}